Doctor profile · Federal record

Dr. Ndidiamaka Obiesie, MD

Infectious Disease Physician (CMS: Infectious Disease) · Internal Medicine Physician · Phoenix, AZ

  • NPI 1770579492
  • Accepts Medicare
  • 29 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3330 N 2Nd St Ste 401
Phoenix, AZ 850122371
(602) 254-1136
fax (602) 279-1720
Mailing address
530 E McDowell RD Ste 107-609
Phoenix, AZ 850041549

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
December 2, 2014
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RI0200X — NUCC code
State license (1)
Arizona #30584
Medicaid
AZ #763062

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770579492. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
655
Distinct HCPCS
3
Medicare allowed
$69,841
HCPCS Description Services Patients Avg allowed
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 336 106 $77
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 178 83 $115
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 141 131 $167

In context: peer comparison

Among 19 peers in Phoenix Infectious Disease Physician, average services per provider: 173. This provider delivers 3.8× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,169
Transactions
78
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
ViiV Healthcare Company 37 $823.14
Gilead Sciences, INC. 13 $405.06
Abbvie INC. 7 $286.79
Shionogi INC 5 $200.56
Melinta Therapeutics, LLC 5 $186.49
Insmed, INC. 3 $66.44
Takeda Pharmaceuticals U.S.A., INC. 2 $58.84
Napo Pharmaceuticals INC 2 $51.33
Theratechnologies INC. 2 $39.07
La Jolla Pharmaceutical Company 1 $27.32
Ardelyx, INC. 1 $23.88

By nature of payment

Food and Beverage
$2,169

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
251
Patients
0
Total drug cost
$526,264
Drug Type Claims Patients Total cost
Biktarvy (Bictegrav/Emtricit/Tenofov Ala) Brand 81 0 $321,169
Dovato (Dolutegravir Sodium/Lamivudine) Brand 30 0 $91,409
Ertapenem (Ertapenem Sodium) Brand 28 0 $16,653
Teflaro (Ceftaroline Fosamil Acetate) Brand 23 0 $60,314
Daptomycin Generic 18 0 $7,951
Ceftriaxone (Ceftriaxone Sodium) Brand 14 0 $3,652
Meropenem Generic 13 0 $1,100
Abacavir-Lamivudine (Abacavir Sulfate/Lamivudine) Brand 11 0 $10,742
Ampicillin Sodium Generic 11 0 $2,133
Atazanavir Sulfate Generic 11 0 $10,883

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ndidiamaka Obiesie's medical specialty?
Dr. Ndidiamaka Obiesie practices Infectious Disease Physician in Phoenix, AZ.
Where does Dr. Ndidiamaka Obiesie practice?
Dr. Ndidiamaka Obiesie practices at 3330 N 2Nd St Ste 401, Phoenix, AZ 850122371. Office phone: 6022541136.
What is Dr. Ndidiamaka Obiesie's NPI?
Dr. Ndidiamaka Obiesie's National Provider Identifier (NPI) is 1770579492, issued by NPPES.
Does Dr. Ndidiamaka Obiesie accept Medicare assignment?
Yes. Dr. Ndidiamaka Obiesie accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ndidiamaka Obiesie commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.